COMPARE · Data as of October 13, 2026

HR vs CTRE

Verdict: Side-by-side breakdown using the Bull Rankings model. HR scored 64.0, CTRE scored 82.0 — CTRE leads.
Compare another set
HR
Healthcare Realty Trust Incorporated
REIT - Healthcare Facilities · Financial strength
66.8Fin
$17.22 · $6.0B
fundamentals as of
Strength gap
5.3
CTRE leads
CTRE
CareTrust REIT, Inc.
REIT - Healthcare Facilities · Financial strength
72.1Fin
$36.56 · $8.6B
fundamentals as of
  • Fastest growthCTRE+61.8%
  • Strongest balance sheetCTRE0.27
THE BULL RANKINGS SCORECARD66.8/ 100 · FIN STRENGTHPEER MEDIANREIT66.8
THE BULL RANKINGS SCORECARD72.1/ 100 · FIN STRENGTHPEER MEDIANREIT72.1
YieldHR5.6%CTRE4.3%
RevHR-7.8%CTRE+61.8%
D/EHR1.03CTRE0.27
HR
CTRE
5.6%A-
Yield
4.3%B+
-7.8%D
Rev
+61.8%A
1.03B
D/E
0.27A
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
HRHealthcare Realty Trust Incorporated
REIT - Healthcare Facilities · $17.22 · beta 0.84
Why now
REIT - Healthcare Facilities · market cap $6.0b. Down 22% from 52-week high of $22.04 — deep drawdown territory. Revenue -8% — in contraction; any catalyst that reverses this triggers re-rating. 12 sell-side analysts rate this a Hold with a mean 1-yr target of $21.42 (implying +24% upside).
Moat
Turnaround / out-of-favor name — GAAP-unprofitable for now, so the durability case is forward-looking: it rests on a recovery (margin normalization, a cyclical upturn or restructuring) or an un-monetized asset (IP / network effects / first-mover position) rather than on current reported results.
Risk
Revenue contracting -8% — the operational turn is not yet visible in the top line. Currently unprofitable (margin -7.6%) — path to GAAP profitability is the core thesis risk. Dividend payout 827% of earnings on a 5.6% yield — distribution coverage is thin; one earnings stumble could force a dividend cut.
CTRECareTrust REIT, Inc.
REIT - Healthcare Facilities · $36.56 · beta 0.77
Why now
REIT - Healthcare Facilities · market cap $8.6b. 16% off the 52-week high of $43.62. Revenue growing +62% — in hypergrowth territory. 13 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $44.62 (implying +22% upside).
Moat
Net margin 62% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma.
Risk
Dividend payout 91% of earnings on a 4.3% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. P/S 15.1x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Common questions

Is CTRE or HR the better stock?

CTRE scores higher: CTRE 82.0, HR 64.0 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.

How are CTRE and HR scored?

Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.

How current is this comparison?

The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.